Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Other Operating Expenses (2016 - 2025)

Pediatrix Medical (MD) has disclosed Other Operating Expenses for 17 consecutive years, with $349.4 million as the latest value for Q2 2025.

  • On a quarterly basis, Other Operating Expenses rose 3313.73% to $349.4 million in Q2 2025 year-over-year; TTM through Dec 2025 was $710.5 million, a 77.25% increase, with the full-year FY2024 number at -$9.7 million, changed N/A from a year prior.
  • Other Operating Expenses was $349.4 million for Q2 2025 at Pediatrix Medical, down from $361.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $410.5 million in Q1 2024 to a low of -$10.9 million in Q2 2024.
  • A 5-year average of $305.3 million and a median of $365.8 million in 2021 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: tumbled 100.01% in 2024, then skyrocketed 3313.73% in 2025.
  • Pediatrix Medical's Other Operating Expenses stood at $368.5 million in 2021, then grew by 10.5% to $407.2 million in 2022, then grew by 0.43% to $408.9 million in 2023, then plummeted by 99.7% to $1.2 million in 2024, then soared by 28239.74% to $349.4 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Other Operating Expenses are $349.4 million (Q2 2025), $361.0 million (Q1 2025), and $1.2 million (Q4 2024).